SCHEMBL2887207

SCHEMBL2887207

CCOC(=O)c1nc(C#N)c2c(c1O)c(Cl)c(Cl)n2Cc1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
MEN1 O00255 1/20 0.40
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 5/20 0.38
POLB P06746 4/20 0.37
SLC26A6 Q9BXS9 2/20 0.37
TP53 P04637 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
GAA P10253 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2887043 0.88 EGLN1 (0.47) KDM4EALDH1A1POLBEGLN1GAA
SCHEMBL2885703 0.87 KMT2A (0.41) KMT2AMEN1KDM4EALDH1A1POLB
SCHEMBL2883578 0.85 POLB (0.39) KMT2AMEN1KDM4EALDH1A1POLB
SCHEMBL2883588 0.84 POLB (0.44) KDM4EALDH1A1POLBSLC26A6SMN1; SMN2
SCHEMBL2885906 0.82 EGLN1 (0.53) EGLN1
SCHEMBL2883549 0.82 ALDH1A1 (0.42) KMT2AMEN1KDM4EALDH1A1POLB
SCHEMBL2884130 0.82 MAPT (0.45) KMT2AMEN1KDM4EALDH1A1POLB
SCHEMBL2885302 0.79 KDM4E (0.48) KMT2AMEN1KDM4EALDH1A1TP53
SCHEMBL2882107 0.79 SMN1; SMN2 (0.42) KMT2AMEN1KDM4EALDH1A1POLB
SCHEMBL2881068 0.78 NPC1 (0.43) KMT2AMEN1KDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124489-B1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2020-07-15 EP disclosed
EP-3124489-A1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS Fibrogen, Inc. (US) 2017-02-01 EP disclosed
EP-2016078-B1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2016-06-15 EP disclosed
US-7696223-B2 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF) FIBROGEN, INC. (US) 2010-04-13 US disclosed
EP-2016078-A2 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN, INC. (US) 2009-01-21 EP disclosed
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF FIBROGEN, INC. 2008-01-03 US disclosed
WO-2007115315-A2 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN, INC. (US) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF HIF1AN, HIF1A, EGLN2 KMT2A 1354/4885MEN1 4211/4885KDM4E 754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.